16 results
8-K
EX-99.1
MRNS
Marinus Pharmaceuticals Inc
27 Mar 24
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review
4:05pm
in scientific research, we will vigorously defend our patents which support our mission of delivering innovative new treatment options to patients … and refractory seizure disorders and remains focused on its mission to bring ganaxolone to patients in need.
About Marinus Pharmaceuticals
Marinus
8-K
EX-99.1
MRNS
Marinus Pharmaceuticals Inc
18 Apr 23
Marinus Pharmaceuticals Appoints Marvin H. Johnson, Jr. to its Board of Directors
7:05am
epilepticus and tuberous sclerosis complex indications and advancing the company’s mission in bringing innovative new treatment options to patients
8-K
EX-99.1
52e qbiof
31 Oct 22
Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agreement with Sagard Healthcare Partners
7:33am
8-K
EX-99.1
uoi2qw2 ahs
12 Aug 20
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
4:07pm
424B5
7w1wxh85mdl
12 Dec 19
Prospectus supplement for primary offering
5:05pm
424B5
iptwnbo4k2l6psnqen
10 Dec 19
Prospectus supplement for primary offering
5:22pm
8-K
EX-99.1
71m3jevel l6
8 Nov 19
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter Financial Results
4:03pm
- Prev
- 1
- Next